Bulk plasma and individual patient samples testing positive for CA19-9. This is a biomedical marker used in the monitoring of treatment response in cancer patients. It is most widely used as a marker for colon cancer and pancreatic cancer. Increased CA19-9 levels are also found in some non-malignant conditions.
| Variant Name | Product Code | Purity | |
|---|---|---|---|
+ |
CA19-9 Positive Serum/Plasma | SH160 | Positive |